NT-3 Activators
NT-3 activators constitute a diverse repertoire of chemicals poised to influence the activity of neurotrophin-3 (NT-3), a pivotal member of the neurotrophin family essential for neuronal survival, development, and function. While direct activators specifically targeting NT-3 may be limited, a nuanced comprehension of the intricate signaling pathways governing NT-3 function allows for the identification of compounds that exert indirect modulation on its activity. Among the compounds listed, agents such as Dibutyryl cAMP, Forskolin, and Rolipram operate through cAMP-dependent pathways. By elevating intracellular cAMP levels, these chemicals activate transcription factors that intricately regulate NT-3 gene expression, offering a potential avenue for augmenting neurotrophic support and fostering neuronal health. Similarly, A769662 and GW501516 function through AMP-activated protein kinase (AMPK) and peroxisome proliferator-activated receptor delta (PPARδ), respectively, influencing NT-3 expression and downstream signaling pathways vital for neuronal regulation.
Conversely, inhibitors such as LY294002, Wortmannin, and SU5402 indirectly impact NT-3 by disrupting key signaling pathways, notably the PI3K/Akt and FGFR cascades. These compounds modulate shared downstream effectors, potentially influencing neurotrophic support and neuronal survival. SB203580, PD98059, and SP600125 function as inhibitors targeting crucial kinases within the MAPK pathway, intersecting with NT-3 signaling and affecting downstream effectors associated with neuronal regulation. Trichostatin A, an epigenetic modulator as a histone deacetylase (HDAC) inhibitor, operates at the chromatin level by altering histone acetylation, potentially enhancing NT-3 gene expression and augmenting neurotrophic support. In conclusion, NT-3 activators, whether direct or indirect, play an indispensable role in unraveling the intricacies of NT-3-mediated neuronal regulation. The discernment of how these chemicals modulate NT-3 expression and downstream pathways enhances our understanding of neurotrophin signaling, providing potential insights for strategies aimed at promoting neuronal health and function.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Dibutyryl-cAMP | 16980-89-5 | sc-201567 sc-201567A sc-201567B sc-201567C | 20 mg 100 mg 500 mg 10 g | $47.00 $136.00 $492.00 $4552.00 | 74 | |
Dibutyryl cAMP activates NT-3 by enhancing cAMP signaling, which can lead to increased expression of neurotrophins. Elevated cAMP levels may activate transcription factors that positively regulate NT-3 gene expression, promoting neurotrophic support. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin activates NT-3 through adenylyl cyclase stimulation, elevating intracellular cAMP levels. This heightened cAMP signaling may lead to the activation of transcription factors, positively influencing NT-3 gene expression. Forskolin's impact on cAMP-dependent pathways can enhance neurotrophic support, potentially benefiting neuronal survival and function. | ||||||
Rolipram | 61413-54-5 | sc-3563 sc-3563A | 5 mg 50 mg | $77.00 $216.00 | 18 | |
Rolipram, a phosphodiesterase inhibitor, increases intracellular cAMP levels. Elevated cAMP can activate transcription factors that positively regulate NT-3 gene expression. Rolipram's impact on cAMP-dependent pathways may enhance neurotrophic support, providing a potential avenue for modulating NT-3 activity and supporting neuronal health. | ||||||
A-769662 | 844499-71-4 | sc-203790 sc-203790A sc-203790B sc-203790C sc-203790D | 10 mg 50 mg 100 mg 500 mg 1 g | $184.00 $741.00 $1076.00 $3417.00 $5304.00 | 23 | |
A769662 activates AMP-activated protein kinase (AMPK), which can influence NT-3 expression through downstream signaling pathways. AMPK activation may modulate transcription factors or other regulators that positively impact NT-3 gene expression, potentially promoting neurotrophic support and enhancing neuronal survival and function. | ||||||
GW501516 | 317318-70-0 | sc-202642 sc-202642A | 1 mg 5 mg | $82.00 $179.00 | 28 | |
GW501516 activates peroxisome proliferator-activated receptor delta (PPARδ), which can influence NT-3 expression through downstream signaling. PPARδ activation may modulate transcription factors or other regulators that positively impact NT-3 gene expression, providing a potential avenue for enhancing neurotrophic support and promoting neuronal health. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
SP600125 inhibits c-Jun N-terminal kinase (JNK), a pathway with connections to neurotrophin signaling. By blocking JNK, SP600125 may indirectly affect NT-3 activity through shared downstream effectors, potentially impacting neuronal survival and function. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
Trichostatin A, a histone deacetylase (HDAC) inhibitor, can influence NT-3 expression epigenetically. By modulating histone acetylation, Trichostatin A may impact the chromatin structure around the NT-3 gene, potentially leading to increased NT-3 expression and enhanced neurotrophic support, benefiting neuronal survival and function. | ||||||